Cantitate/Preț
Produs

Structural Bioinformatics: Applications in Preclinical Drug Discovery Process: Challenges and Advances in Computational Chemistry and Physics, cartea 27

Editat de C. Gopi Mohan
en Limba Engleză Hardback – 23 ian 2019
This book reviews the advances and challenges of structure-based drug design in the preclinical drug discovery process, addressing various diseases, including malaria, tuberculosis and cancer. Written by internationally recognized researchers, this edited book discusses how the application of the various in-silico techniques, such as molecular docking, virtual screening, pharmacophore modeling, molecular dynamics simulations, and residue interaction networks offers insights into pharmacologically active novel molecular entities. It presents a clear concept of the molecular mechanism of different drug targets and explores methods to help understand drug resistance. In addition, it includes chapters dedicated to natural-product- derived medicines, combinatorial drug discovery, the CryoEM technique for structure-based drug design and big data in drug discovery.

The book offers an invaluable resource for graduate and postgraduate students, as well as forresearchers in academic and industrial laboratories working in the areas of chemoinformatics, medicinal and pharmaceutical chemistry and pharmacoinformatics.
Citește tot Restrânge

Din seria Challenges and Advances in Computational Chemistry and Physics

Preț: 109718 lei

Preț vechi: 133802 lei
-18% Nou

Puncte Express: 1646

Preț estimativ în valută:
21001 22021$ 17352£

Carte tipărită la comandă

Livrare economică 29 ianuarie-12 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030052812
ISBN-10: 3030052818
Pagini: 585
Ilustrații: XII, 406 p. 106 illus., 79 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.76 kg
Ediția:1st ed. 2019
Editura: Springer International Publishing
Colecția Springer
Seria Challenges and Advances in Computational Chemistry and Physics

Locul publicării:Cham, Switzerland

Cuprins

Free Energy based methods to understand drug resistant mutations.- Structure-based inhibitor design for some multi-targeted drugs and its ADMET profile.- Structure-based drug design in anti-malarial agent identification.- Epigenome - the guide to genomic expression for different diseases.- Structure-based design towards Anti-Alzheimer agents.- Challenges of Structure-based drug design and discovery.

Notă biografică

Dr. C. Gopi Mohan is an Associate Professor at the Center for Nanosciences and Molecular Medicine, specializing in the areas of structural bioinformatics, structure-based drug design, protein crystallography, and nanoinformatics. He graduated from Banaras Hindu University with a PhD in Physics and gained experience as a postdoctoral researcher at the Indian Institute of Science, Bangalore (India), as a research officer at the University of Bath (UK) and as an associate researcher at the University Henri Poincare, Nancy (France). Further, he worked as a member of the faculty at the National Institute of Pharmaceutical Education & Research (NIPER), Mohali, Punjab. Dr. Gopi Mohan has published more than 70 research papers in refereed journals and was cited as an internationally recognized expert in the field of Structural Bioinformatics and Chemoinformatics by Synergix Ltd. (UK) founded by Dr. N.C. Cohen, a pioneer of rational drug design. Recently he was awarded the ICMR Senior Biomedical Scientist International Fellowship to visit US laboratories for research collaborations.

Textul de pe ultima copertă

This book reviews the advances and challenges of structure-based drug design in the preclinical drug discovery process, addressing various diseases, including malaria, tuberculosis and cancer. Written by internationally recognized researchers, this edited book discusses how the application of the various in-silico techniques, such as molecular docking, virtual screening, pharmacophore modeling, molecular dynamics simulations, and residue interaction networks offers insights into pharmacologically active novel molecular entities. It presents a clear concept of the molecular mechanism of different drug targets and explores methods to help understand drug resistance. In addition, it includes chapters dedicated to natural-product- derived medicines, combinatorial drug discovery, the CryoEM technique for structure-based drug design and big data in drug discovery.

The book offers an invaluable resource for graduate and postgraduate students, as well as for researchers in academic and industrial laboratories working in the areas of chemoinformatics, medicinal and pharmaceutical chemistry and pharmacoinformatics.

Caracteristici

Examines successes, risks, and challenges of in-silico drug discovery Offers integrated case studies, including a discussion of drug resistance with respect to structure-based drug design Reviews the application of big data in drug discovery